TSANZ SIG Orals: COPD 2
Tracks
TSANZ Orals
Sunday, March 23, 2025 |
1:00 PM - 2:30 PM |
Riverbank 1 |
Speaker
Miss Prerna Mehta
Medical Science Liaision
Sanofi
Dupilumab in COPD with type 2 inflammation: Pooled BOREAS/NOTUS trials
1:00 PM - 1:15 PMBiography
Prerna Mehta is a Medical Science Liaison at Sanofi.
Back up presenter: Caroline Markey. Caroline Markey, PhD is a senior level medical scientific professional at Sanofi.
Dr Thomas Bradbury
Project Coordinator
The George Institute for Global Health
Low-dose bisoprolol does not cause acute worsening in COPD patient respiratory status: an updated PACE in COPD sub-analysis
1:15 PM - 1:30 PMBiography
Dr Bradbury is a post-doctoral researcher and program coordinator at the George Institute for Global Health. His work current work focuses on developing human research training programs for clinical staff in hospitals, but he also retains a keen interest in the development of low-cost COPD interventions.
Dr Lee Fong
Medical Advisor
Australian Commission on Safety and Quality in Health Care
A national standard to improve care for chronic obstructive pulmonary disease
1:30 PM - 1:45 PMBiography
Lee chaired the Topic Working Group for the COPD Clinical Care Standard. He is a practising GP who provides leadership in primary care projects at the Commission. He also has roles in clinical governance, service development, guideline development and advocacy. Lee has a keen interest in organisational collaboration and innovation to bring about system changes and improve healthcare equity.
Dr Sanjay Ramakrishnan
Senior Lecturer
Institute for Respiratory Health
Benralizumab for eosinophilic asthma and/or COPD exacerbations (ABRA trial)
1:45 PM - 2:00 PMBiography
Dr Sanjay Ramakrishnan is a respiratory physician and senior lecturer at the Institute for Respiratory Health, University of Western Australia. His clinical and research focus on the assessment and treatment of asthma and COPD exacerbations.
Dr Arwel Jones
Research Fellow
Monash University
Oral corticosteroid use in COPD: a national consumer survey
2:00 PM - 2:15 PMBiography
Dr Arwel Jones is a Research Fellow at Respiratory Research@Alfred, Monash University. Arwel is currently the convenor of the TSANZ COPD SIG. Arwel's research investigates the prevention and treatment of exacerbations of chronic lung disease and respiratory infections including areas such as pulmonary rehabilitation, vaccinations and oral corticosteroids.
Dr Belinda Cochrane
Respiratory And Sleep Physician
Campbelltown Hospital
High-risk COPD patient management opportunities: Australia, US and UK comparisons
2:15 PM - 2:30 PMBiography
Belinda Cochrane is Respiratory and Sleep Medicine Physician at Macarthur Health and Conjoint Professor with Western Sydney University. She is reviewer for the COPD-X Guidelines Committee contributing to the section about cardiovascular disease. Her main research interests include models of care for COPD, breathlessness and inhaler device capability.
Mr Dinh Bui
Senior Research Fellow
University of Melbourne
Chairperson
Biography
Assoc Prof Philip Masel
Thoracic Physician
The Prince Charles Hospital
Chairperson
Biography
